Psychedelic therapy company Field Trip inks C$95m in funding

Field Trip Health, a Toronto-based developer of psychedelic therapies, has closed a C$95 million equity financing.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this